A recently published article in the NEJM in which Haskal et al compared POBA in hemodialysis access grafts versus Bard's Flair stent graft in a prospective, randomized fashion showed a statistically significant patency benefit as well as freedom from restenosis for the covered graft from Bard. Although this study looked at short term results and it is unlcear what the severity of recurrence will be for the covered stent device-the study makes a compelling argument that POBA for HD grafts is losing favor.
6 month patency 51% vs 23% in stent graft vs POBA
binary restenosis greater in POBA group vs stent graft 78% 28% respectively
It's nice article. And it's really with full information. Thanks for sharing!
Posted by: ClubPenguinCheats | April 28, 2011 at 11:22 PM